Pharmacokinetic Analysis of an Isoniazid Suspension Among Spanish Children Under 6 Years of Age

Pharmacokinetic Analysis of an Isoniazid Suspension Among Spanish Children Under 6 Years of Age

<b>Background</b>: Isoniazid (INH) remains a first-line drug for the treatment of tuberculosis (TB) in young children. In 2010, the WHO recommended an increase in the daily dose of INH up to 10 (7–15) mg/kg. Currently, there are no INH suspensions available in Europe. <b>Methods<...

Full description

Saved in:
Bibliographic Details
Main Authors: Antoni Noguera-Julian, Emma Wilhelmi, Maria Cussó, Rob Aarnoutse, Angela Colbers, Loreto Martorell, Maria Goretti López-Ramos, Joan Vinent, Rosa Farré, Dolors Soy, Sílvia Simó-Nebot, Clàudia Fortuny
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Antibiotics
Subjects:
acetylator status
child
isoniazid
pharmacokinetics
suspension
tuberculosis
Online Access:https://www.mdpi.com/2079-6382/14/1/74
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items